Article Type
Article
Changed
Tue, 10/03/2023 - 14:37
Display Headline
Data Trends 2023: Opioid Use Disorder

Click to view more from Federal Health Care Data Trends 2023.

References

7. Bennett AS et al. Ann Med. 2022;54(1):1826-1838. doi:10.1080/07853890.2022.2092896
8. Finlay AK et al. Am J Prev Med. 2022;62(1):e29-e37. doi:10.1016/j.amepre.2021.06.014
9. Peltier MR et al. J Dual Diagn. 2021;17(2):124-134. doi:10.1080/15504263.2021.1904162
10. Beckman KL et al. Am J Prev Med. 2022;62(3):377-386. doi:10.1016/j.amepre.2021.08.020
11. Boyer TL et al. Am J Prev Med. 2022;63(2):168-177. doi:10.1016/j.amepre.2022.02.011
12. Jasuja GK et al. Med Care. 2021;59(suppl 2):S165-S169. doi:10.1097/MLR.0000000000001437
13. US Department of Veterans Affairs, Office of Public and Intergovernmental Affairs. VA’s Rapid Naloxone Initiative recognized in fight against opioid overdose deaths. Published June 8, 2021. Accessed April 21, 2023. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5679 
14. Chen EF, et. al. Fed Pract. 2022;39(3):136-141. doi:10.12788/fp.0236

Publications
Federal Practitioner
Topics
Mental Health

Click to view more from Federal Health Care Data Trends 2023.

Click to view more from Federal Health Care Data Trends 2023.

References

7. Bennett AS et al. Ann Med. 2022;54(1):1826-1838. doi:10.1080/07853890.2022.2092896
8. Finlay AK et al. Am J Prev Med. 2022;62(1):e29-e37. doi:10.1016/j.amepre.2021.06.014
9. Peltier MR et al. J Dual Diagn. 2021;17(2):124-134. doi:10.1080/15504263.2021.1904162
10. Beckman KL et al. Am J Prev Med. 2022;62(3):377-386. doi:10.1016/j.amepre.2021.08.020
11. Boyer TL et al. Am J Prev Med. 2022;63(2):168-177. doi:10.1016/j.amepre.2022.02.011
12. Jasuja GK et al. Med Care. 2021;59(suppl 2):S165-S169. doi:10.1097/MLR.0000000000001437
13. US Department of Veterans Affairs, Office of Public and Intergovernmental Affairs. VA’s Rapid Naloxone Initiative recognized in fight against opioid overdose deaths. Published June 8, 2021. Accessed April 21, 2023. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5679 
14. Chen EF, et. al. Fed Pract. 2022;39(3):136-141. doi:10.12788/fp.0236

References

7. Bennett AS et al. Ann Med. 2022;54(1):1826-1838. doi:10.1080/07853890.2022.2092896
8. Finlay AK et al. Am J Prev Med. 2022;62(1):e29-e37. doi:10.1016/j.amepre.2021.06.014
9. Peltier MR et al. J Dual Diagn. 2021;17(2):124-134. doi:10.1080/15504263.2021.1904162
10. Beckman KL et al. Am J Prev Med. 2022;62(3):377-386. doi:10.1016/j.amepre.2021.08.020
11. Boyer TL et al. Am J Prev Med. 2022;63(2):168-177. doi:10.1016/j.amepre.2022.02.011
12. Jasuja GK et al. Med Care. 2021;59(suppl 2):S165-S169. doi:10.1097/MLR.0000000000001437
13. US Department of Veterans Affairs, Office of Public and Intergovernmental Affairs. VA’s Rapid Naloxone Initiative recognized in fight against opioid overdose deaths. Published June 8, 2021. Accessed April 21, 2023. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5679 
14. Chen EF, et. al. Fed Pract. 2022;39(3):136-141. doi:10.12788/fp.0236

Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
Mental Health
Article Type
Article
Display Headline
Data Trends 2023: Opioid Use Disorder
Display Headline
Data Trends 2023: Opioid Use Disorder
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Slideshow
Gate On Date
Wed, 09/20/2023 - 12:15
Un-Gate On Date
Wed, 09/20/2023 - 12:15
Use ProPublica
CFC Schedule Remove Status
Wed, 09/20/2023 - 12:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article Slideshow Optional Introduction

Slideshow below.

The rate of opioid overdose mortality in veterans increased rapidly over the last decade.7 Several characteristics have been shown to affect opioid-related mortality in veterans—factors such as legal involvement, military sexual trauma, gender identity, and homelessness status.8-12 While widespread initiatives are working to address these issues—with some VA programs demonstrating successful and significant reductions in opioid overdoses13—there is still much work to be done.

Slide
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Slide Media